1 Table of Contents 2
1.1 List of Figures 4
1.2 List of Tables 5

2 Executive Summary 7
2.1 Report Guide 9
2.2 Key Findings 10
2.2.1 Overview of Global Clinical Trials Initiated in 2017 10
2.2.2 Average Enrolment by Country, 2010- 2017 11
2.2.3 Prominent Companies in Global Oligodendroglioma Trials, 2010- 2017 12

3 Oligodendroglioma Drugs in Ongoing and Completed Trials 13
3.1 Prominent Drugs in Development and Approved Stages for Oligodendroglioma 13
3.2 Oligodendroglioma Product Snapshots 14
3.2.1 Oligodendroglioma Drug Profiles 14

4 Global Oligodendroglioma Clinical Trial Research Trends 17
4.1 Clinical Trials by Top 10 Countries, 2010- 2017 17
4.1.1 Clinical Trials by Country 17
4.1.2 Number of Ongoing/Planned Trial Locations in Each Country 18
4.2 Subjects Recruited by Top 10 Countries, 2010- 2017 19
4.2.1 Total Enrolment by Country 19
4.3 Clinical Trials by Region, 2010- 2017 20
4.4 Subjects Recruited by Region, 2010- 2017 21
4.5 Clinical Trials by Year, 2010- 2017 22
4.6 Subjects Recruited by Year, 2010- 2017 23
4.7 Clinical Trials by Development Phase, 2010- 2017 24
4.7.1 Clinical Trials by Phase 24
4.8 Subjects Recruited by Development Phase, 2010- 2017 25
4.9 Clinical Trials by Status, 2010- 2017 26
4.10 Subjects Recruited by Trial Status, 2010- 2017 27
4.11 Clinical Trials by Sponsor Type, 2010- 2017 28
4.12 Subjects Recruited by Sponsor Type, 2010- 2017 29
4.13 Clinical Trials by Economy Type, 2010- 2017 30
4.14 Clinical Trials and Subjects Recruited by Study Type, 2010- 2017 31

5 Europe Oligodendroglioma Clinical Trial Research Trends 32
5.1 Clinical Trials by Top Countries in Europe, 2010- 2017 32
5.1.1 Europe, Clinical Trials by Country 32
5.2 Subjects Recruited by Top Countries in Europe, 2010- 2017 33
5.2.1 Europe, Total Enrolment by Country 33
5.3 Europe, Clinical Trials by Year, 2010- 2017 34
5.4 Europe, Clinical Trials by Development Phase, 2010- 2017 35
5.5 Europe, Clinical Trials by Trial Status, 2010- 2017 36
5.6 Europe, Clinical Trials by Sponsor Type, 2010- 2017 37

6 North America Oligodendroglioma Clinical Trial Research Trends 38
6.1 Clinical Trials by Top Countries in North America, 2010- 2017 38
6.1.1 North America, Clinical Trials by Country 38
6.2 Subjects Recruited by Top Countries in North America, 2010- 2017 39
6.2.1 North America, Total Enrolment by Country 39
6.3 North America, Clinical Trials by Year, 2010- 2017 40
6.4 North America, Clinical Trials by Development Phase, 2010- 2017 41
6.5 North America, Clinical Trials by Trial Status, 2010- 2017 42
6.6 North America, Clinical Trials by Sponsor Type, 2010- 2017 43

7 Western Pacific Oligodendroglioma Clinical Trial Research Trends 44
7.1 Clinical Trials by Top Countries in Western Pacific, 2010- 2017 44
7.1.1 Western Pacific, Clinical Trials by Country 44
7.2 Subjects Recruited by Top Countries in Western Pacific, 2010- 2017 45
7.2.1 Western Pacific, Total Enrolment by Country 45
7.3 Western Pacific, Clinical Trials by Year, 2010- 2017 46
7.4 Western Pacific, Clinical Trials by Development Phase, 2010- 2017 47
7.5 Western Pacific, Clinical Trials by Trial Status, 2010- 2017 48
7.6 Western Pacific, Clinical Trials by Sponsor Type, 2010- 2017 49

8 Recent Clinical Trials- Snapshots 50
8.1 Oligodendroglioma Trial Snapshots- 2018 50
8.2 Oligodendroglioma Trial Snapshots- 2017 51
8.3 Oligodendroglioma Trial Snapshots- 2016 59
8.4 Oligodendroglioma Trial Snapshots- 2015 65
8.5 Oligodendroglioma Trial Snapshots- 2014 68
8.6 Oligodendroglioma Trial Snapshots- 2013 74
8.7 Oligodendroglioma Trial Snapshots- 2012 79
8.8 Oligodendroglioma Trial Snapshots- 2011 92
8.9 Oligodendroglioma Trial Snapshots- 2010 97

9 Appendix 108
9.1 About VPA Research 108
9.2 Sources and Research Methodology 109

1.1 List of Figures
Figure 1: Oligodendroglioma- Average Enrolment by Country, 2010- 2017 11
Figure 2: Oligodendroglioma- Country wise Clinical Trials, 2010- 2017 17
Figure 3: Oligodendroglioma- Country wise Recruiting Sites, 2010- 2017 18
Figure 4: Oligodendroglioma- Country wise Subjects Recruited, 2010- 2017 19
Figure 5: Global Oligodendroglioma Clinical Trials Participation Share by Region, 2010- 2017 20
Figure 6: Global Oligodendroglioma Subjects Recruited by Region, 2010- 2017 21
Figure 7: Global Oligodendroglioma Clinical Trials by Year, 2010- 2017 22
Figure 8: Global Oligodendroglioma Subjects Recruited by Year, 2010- 2017 23
Figure 9: Global Oligodendroglioma Trials by Phase, 2010- 2017 24
Figure 10: Global Oligodendroglioma- Subjects Recruited by Phase, 2010- 2017 25
Figure 11: Global Oligodendroglioma- Clinical Trials by Recruitment Status, 2010- 2017 26
Figure 12: Global Oligodendroglioma- Subjects Recruited by Trial Status, 2010- 2017 27
Figure 13: Global Oligodendroglioma- Clinical Trials by Sponsor Type, 2010- 2017 28
Figure 14: Global Oligodendroglioma- Subjects Recruited by Trial Status, 2010- 2017 29
Figure 15: Global Oligodendroglioma- Clinical Trials by Type of Economy, 2010- 2017 30
Figure 16: Europe Oligodendroglioma- Country wise Clinical Trials, 2010- 2017 32
Figure 17: Europe Oligodendroglioma- Country wise Subjects Recruited, 2010- 2017 33
Figure 18: Europe Oligodendroglioma- Year wise Clinical Trials, 2010- 2017 34
Figure 19: Europe Oligodendroglioma Trials by Phase, 2010- 2017 35
Figure 20: Europe Oligodendroglioma- Clinical Trials by Recruitment Status, 2010- 2017 36
Figure 21: Europe Oligodendroglioma- Clinical Trials by Sponsor Type, 2010- 2017 37
Figure 22: North America Oligodendroglioma- Country wise Clinical Trials, 2010- 2017 38
Figure 23: North America Oligodendroglioma- Country wise Subjects Recruited, 2010- 2017 39
Figure 24: North America Oligodendroglioma- Year wise Clinical Trials, 2010- 2017 40
Figure 25: North America Oligodendroglioma Trials by Phase, 2010- 2017 41
Figure 26: North America Oligodendroglioma- Clinical Trials by Recruitment Status, 2010- 2017 42
Figure 27: North America Oligodendroglioma- Clinical Trials by Sponsor Type, 2010- 2017 43
Figure 28: Western Pacific Oligodendroglioma- Country wise Clinical Trials, 2010- 2017 44
Figure 29: Western Pacific Oligodendroglioma- Country wise Subjects Recruited, 2010- 2017 45
Figure 30: Western Pacific Oligodendroglioma- Year wise Clinical Trials, 2010- 2017 46
Figure 31: Western Pacific Oligodendroglioma Trials by Phase, 2010- 2017 47
Figure 32: Western Pacific Oligodendroglioma- Clinical Trials by Recruitment Status, 2010- 2017 48
Figure 33: Western Pacific Oligodendroglioma- Clinical Trials by Sponsor Type, 2010- 2017 49

1.2 List of Tables
Table 1: Oligodendroglioma Pipeline Drug Profiles- Type, Class, Route of Administration, Mechanism of Action, Target (1) 14
Table 2: Oligodendroglioma Pipeline Drug Profiles- Type, Class, Route of Administration, Mechanism of Action, Target (2) 15
Table 3: Oligodendroglioma Pipeline Drug Profiles- Type, Class, Route of Administration, Mechanism of Action, Target (3) 16
Table 4: Oligodendroglioma- Region wise Clinical Trials, 2010- 2017 20
Table 5: Oligodendroglioma- Region wise Subjects Recruited, 2010- 2017 21
Table 6: Global Oligodendroglioma- Clinical Trials and Subjects by Trial Type, 2010- 2017 31
Table 7: Oligodendroglioma Trial Snapshots- 2018 50
Table 8: Oligodendroglioma Trial Snapshots- 2017 51
Table 9: Oligodendroglioma Trial Snapshots- 2017 52
Table 10: Oligodendroglioma Trial Snapshots- 2017 53
Table 11: Oligodendroglioma Trial Snapshots- 2017 54
Table 12: Oligodendroglioma Trial Snapshots- 2017 55
Table 13: Oligodendroglioma Trial Snapshots- 2017 56
Table 14: Oligodendroglioma Trial Snapshots- 2017 57
Table 15: Oligodendroglioma Trial Snapshots- 2017 58
Table 16: Oligodendroglioma Trial Snapshots- 2016 59
Table 17: Oligodendroglioma Trial Snapshots- 2016 60
Table 18: Oligodendroglioma Trial Snapshots- 2016 61
Table 19: Oligodendroglioma Trial Snapshots- 2016 62
Table 20: Oligodendroglioma Trial Snapshots- 2016 63
Table 21: Oligodendroglioma Trial Snapshots- 2016 64
Table 22: Oligodendroglioma Trial Snapshots- 2015 65
Table 23: Oligodendroglioma Trial Snapshots- 2015 66
Table 24: Oligodendroglioma Trial Snapshots- 2015 67
Table 25: Oligodendroglioma Trial Snapshots- 2014 68
Table 26: Oligodendroglioma Trial Snapshots- 2014 69
Table 27: Oligodendroglioma Trial Snapshots- 2014 70
Table 28: Oligodendroglioma Trial Snapshots- 2014 71
Table 29: Oligodendroglioma Trial Snapshots- 2014 72
Table 30: Oligodendroglioma Trial Snapshots- 2014 73
Table 31: Oligodendroglioma Trial Snapshots- 2013 74
Table 32: Oligodendroglioma Trial Snapshots- 2013 75
Table 33: Oligodendroglioma Trial Snapshots- 2013 76
Table 34: Oligodendroglioma Trial Snapshots- 2013 77
Table 35: Oligodendroglioma Trial Snapshots- 2013 78
Table 36: Oligodendroglioma Trial Snapshots- 2012 79
Table 37: Oligodendroglioma Trial Snapshots- 2012 80
Table 38: Oligodendroglioma Trial Snapshots- 2012 81
Table 39: Oligodendroglioma Trial Snapshots- 2012 82
Table 40: Oligodendroglioma Trial Snapshots- 2012 83
Table 41: Oligodendroglioma Trial Snapshots- 2012 84
Table 42: Oligodendroglioma Trial Snapshots- 2012 85
Table 43: Oligodendroglioma Trial Snapshots- 2012 86
Table 44: Oligodendroglioma Trial Snapshots- 2012 87
Table 45: Oligodendroglioma Trial Snapshots- 2012 88
Table 46: Oligodendroglioma Trial Snapshots- 2012 89
Table 47: Oligodendroglioma Trial Snapshots- 2012 90
Table 48: Oligodendroglioma Trial Snapshots- 2012 91
Table 49: Oligodendroglioma Trial Snapshots- 2011 92
Table 50: Oligodendroglioma Trial Snapshots- 2011 93
Table 51: Oligodendroglioma Trial Snapshots- 2011 94
Table 52: Oligodendroglioma Trial Snapshots- 2011 95
Table 53: Oligodendroglioma Trial Snapshots- 2011 96
Table 54: Oligodendroglioma Trial Snapshots- 2010 97
Table 55: Oligodendroglioma Trial Snapshots- 2010 98
Table 56: Oligodendroglioma Trial Snapshots- 2010 99
Table 57: Oligodendroglioma Trial Snapshots- 2010 100
Table 58: Oligodendroglioma Trial Snapshots- 2010 101
Table 59: Oligodendroglioma Trial Snapshots- 2010 102
Table 60: Oligodendroglioma Trial Snapshots- 2010 103
Table 61: Oligodendroglioma Trial Snapshots- 2010 104
Table 62: Oligodendroglioma Trial Snapshots- 2010 105
Table 63: Oligodendroglioma Trial Snapshots- 2010 106
Table 64: Oligodendroglioma Trial Snapshots- 2010 107